Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 1999

View Archived Issues

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

Fujisawa updates R&D activities for FY 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

Ribonucleoside reductase inhibitors with anti-HIV activity in development at Molecules for Health

Proteus and Therapeutic Antibodies propose merger

NeuroSearch-Meiji Seika team discovers positive modulators of GABA-A receptor complex

New MMP/TNF production inhibitors presented by DuPont

Ortho-McNeil describes new dipyridoimidazole series of GABA-A receptor ligands

Immunosuppressive and antifungal sphingosine derivatives from Takara Shuzo

Yoshitomi discloses new antipsychotics in recent patent literature

News from DDW: rhIL-11 has potential in the treatment of pancreatitis

Improved PDE4 inhibitors in development at Merck Frosst

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

Japanese herbal medicine improves symptoms of nonulcer dyspepsia

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

ViroPharma to advance new anti-RSV candidate to clinical trials

Systematic review of published studies questions efficacy of carbamazepine in cocaine dependency

Avigen cleared to begin human trials of gene therapy product for hemophilia

New series with potential in HCV disease advances through the ViroPharma pipeline

NeoPharm outlines developments during the first quarter

M-100907: a potential treatment for coexisting cocaine dependence and schizophrenia

SmithKline Beecham launches antidiarrheal drug in the Philippines

Fluvoxamine maleate launched in Japan for social anxiety disorder

Humanized antibody-cytokine fusion protein demonstrates immunological activity in phase I trial

CPMP adopts positive opinion on Synagis for RSV prevention

Flavonoid derivative DA-6034 is active in animal models of IBD

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

News from APA: bupropion SR suggested to hold promise as an antiobesity treatment

Avandia receives FDA approval for treatment of type II diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...